FDA says court-ordered approval of Teva Pharmaceutical Industries Ltd.’sPlan B One-Step OTC switch application would be inappropriate and encroach on the agency’s statutory authority.
The agency and Teva subsidiary Teva Women's Health Inc. separately filed documents March 9 with the U.S
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?